Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-18

FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) by Eisai Inc. This action updates the product's labeling per the supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)

Snippet

SUPPL AP for ARICEPT (DONEPEZIL HYDROCHLORIDE)